Literature DB >> 13673714

Depressive states and drugs; a study of the use of imipramine tofranil in open psychiatric settings.

G J SARWER-FONER, H GRAUER, J MACKAY, E K KORANYI.   

Abstract

Entities:  

Keywords:  TRANQUILIZING AGENTS/therapeutic use

Mesh：

Substances：

Year:  1959        PMID： 13673714

Source DB:  PubMed          Journal:  Med Serv J Can        ISSN： 0368-9204


× No keyword cloud information.
  7 in total

1.  A clinical analysis of the effects of tofranil in depression. Longitudinal and follow-up studies. Treatment of blood-relations.

Authors:  J ANGST
Journal:  Psychopharmacologia       Date:  1961-12-19

2.  Myocardial infarction during imipramine treatment of depression.

Authors:  L SLOMAN
Journal:  Can Med Assoc J       Date:  1960-01-02       Impact factor: 8.262

3.  Recognition and management of drug-induced extra-pyramidal reactions and "paradoxical" behavioural reactions in psychiatry.

Authors:  G J SARWER-FONER
Journal:  Can Med Assoc J       Date:  1960-08-13       Impact factor: 8.262

4.  The electrocardiogram and its interpretation: a study of reports by 20 physicians on a set of 100 electrocardiograms.

Authors:  H N SEGALL
Journal:  Can Med Assoc J       Date:  1960-01-02       Impact factor: 8.262

5.  Use of imipramine (Tofranil) in psychiatric patients of a geriatric outpatient clinic.

Authors:  H GRAUER; V A KRAL
Journal:  Can Med Assoc J       Date:  1960-12-31       Impact factor: 8.262

6.  Depressive states and drugs. III. Use of methylphenidate (Ritalin) in open psychiatric settings and in office practice.

Authors:  A B KERENYI; E K KORANYI; G J SARWER-FONER
Journal:  Can Med Assoc J       Date:  1960-12-10       Impact factor: 8.262

7.  Clinical investigation of trifluoperazine (stelazine) in open psychiatric settings.

Authors:  G J SARWER-FONER; E K KORANYI; J MACKAY; H GRAUER
Journal:  Can Med Assoc J       Date:  1959-11-01       Impact factor: 8.262
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.